TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling

  • Mol Ther. 2024 Feb 7;32(2):325-339. doi: 10.1016/j.ymthe.2023.11.029.
Sandeep R P Kumar  1 Moanaro Biswas  1 Di Cao  1 Sreevani Arisa  1 Maite Muñoz-Melero  1 Anh K Lam  1 Annie R Piñeros  1 Reuben Kapur  1 Tsuneyasu Kaisho  2 Randal J Kaufman  3 Weidong Xiao  1 Dmitry M Shayakhmetov  4 Cox Terhorst  5 Ype P de Jong  6 Roland W Herzog  7
Affiliations
  • 1. Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA.
  • 2. Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
  • 3. Center for Genetic Disorders and Aging Research, Samford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
  • 4. Lowance Center for Human Immunology, Emory Vaccine Center, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • 5. Division of Immunology, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.
  • 6. Division of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, NY, USA.
  • 7. Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University, Indianapolis, IN, USA. Electronic address: [email protected].
Abstract

Upon viral Infection of the liver, CD8+ T cell responses may be triggered despite the immune suppressive properties that manifest in this organ. We sought to identify pathways that activate responses to a neoantigen expressed in hepatocytes, using adeno-associated viral (AAV) gene transfer. It was previously established that cooperation between plasmacytoid dendritic cells (pDCs), which sense AAV genomes by Toll-like Receptor 9 (TLR9), and conventional DCs promotes cross-priming of capsid-specific CD8+ T cells. Surprisingly, we find local initiation of a CD8+ T cell response against antigen expressed in ∼20% of murine hepatocytes, independent of TLR9 or type I interferons and instead relying on IL-1 receptor 1-MyD88 signaling. Both IL-1α and IL-1β contribute to this response, which can be blunted by IL-1 blockade. Upon AAV administration, IL-1-producing pDCs infiltrate the liver and co-cluster with XCR1+ DCs, CD8+ T cells, and Kupffer cells. Analogous events were observed following coagulation Factor VIII gene transfer in hemophilia A mice. Therefore, pDCs have alternative means of promoting anti-viral T cell responses and participate in intrahepatic immune cell networks similar to those that form in lymphoid organs. Combined TLR9 and IL-1 blockade may broadly prevent CD8+ T responses against AAV capsid and transgene product.

Keywords
AAV; CD8(+) T cell; IL-1; IL-1 receptor; Kupffer cell; Toll-like receptor; innate immunity; liver gene therapy; plasmacytoid dendritic cell.
Products